Results 141 to 150 of about 13,546 (186)

Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder. [PDF]

open access: yesFront Immunol
Wang L   +13 more
europepmc   +1 more source

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Rommer PS   +31 more
europepmc   +1 more source

Distinct remission immune architectures under rituximab and azathioprine in AQP4-IgG-positive neuromyelitis optica spectrum disorder. [PDF]

open access: yesFront Immunol
Shin W   +11 more
europepmc   +1 more source

Neuromyelitis optica

Current Treatment Options in Neurology, 2005
Neuromyelitis optica (Devic's syndrome) is an uncommon, idiopathic, demyelinating syndrome of the central nervous system that preferentially affects the optic nerves and spinal cord. It frequently is misdiagnosed as severe multiple sclerosis, but usually is readily distinguished from multiple sclerosis in fully developed cases because of its severity ...
Dean M, Wingerchuk, Brian G, Weinshenker
  +9 more sources

Neuromyelitis optica

Nature Reviews Disease Primers, 2020
Neuromyelitis optica (NMO; also known as Devic syndrome) is a clinical syndrome characterized by attacks of acute optic neuritis and transverse myelitis. In most patients, NMO is caused by pathogenetic serum IgG autoantibodies to aquaporin 4 (AQP4), the most abundant water-channel protein in the central nervous system.
Sven, Jarius   +5 more
openaire   +4 more sources

Neuromyelitis Optica

Current Treatment Options in Neurology, 2010
Neuromyelitis optica (NMO) or Devic's disease typically involves the optic nerves and the spinal cord and is most often relapsing. The pathogenesis is one of an acute inflammatory process targeting astrocytes and resulting in demyelination, as well as axonal injury.
William M, Carroll, Kazuo, Fujihara
openaire   +4 more sources

Neuromyelitis optica and neuromyelitis optica spectrum disorders

Current Opinion in Neurology, 2017
Purpose of review The discovery of highly specific auto-antibodies directed against the water channel aquaporin 4 was a quantum leap in the definition, classification and management of neuromyelitis optica (NMO). Herein, we propose an update on epidemiological, clinical and therapeutic advances in the field, underlining unmet ...
Romain, Marignier   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy